Form 4: SOPHiA GENETICS SA CEO Sells Shares
Insider Transaction (Form 4)
Ross Muken, Chief Executive Officer and a Director of SOPHiA GENETICS SA, sold 422 shares of common stock on September 21, 2026 for $8.33 per share.
Summary
- Open-market sale: disposed of 422 Ordinary Shares at $8.33 ($3,515) on September 21, 2026; holds 670,229 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $3,515 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Ross Muken — Director, Officer (Chief Executive Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-21 | Open-market sale | Ordinary Shares | 422 | $8 | $3.5K | 670,229 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-21 | Open-market sale (422 shares) |
Keywords
insider transaction, Form 4, SOPH, SOPHiA GENETICS SA, bearish, Ross Muken
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.